RYONCIL

Mesoblast🇺🇸 United States

FDA Page

Effective Date: Mar 3, 2025
Approval ID: a4e0918f-7444-4694-adeb-d38d98345659
Products: 8 registered
Version: 2

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use RYONCIL safely and effectively. See full prescribing information for RYONCIL. RYONCIL (remestemcel-L-rknd) suspension for intravenous infusion Initial U.S. Approval: December 2024

Quick Stats

Total Products8

Labelers2

Label Sections25

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.